振德醫療(603301.SH):以4513萬元競得紹興濱海新區工業用地
格隆匯7月29日丨振德醫療(603301.SH)公佈,此前披露,公司於2021年2月9日召開第二屆董事會第十五次會議審議通過了《關於投資新型防護用品、手術通路類醫療器械生產基地及醫用生物新材料研究院建設項目的議案》,根據公司戰略發展和業務發展需要,結合公司經營現狀,為進一步拓展公司產品和業務佈局,提升公司研發創新和核心技術能力,公司董事會同意在浙江省紹興濱海新區以公開競買方式取得國有建設用地使用權(土地面積預計約100畝),投資建設新型防護用品、手術通路類醫療器械生產基地及醫用生物新材料研究院建設項目,項目總投資合計約6.5億元。
根據上述董事會決議,公司於近日參與了紹興濱海新區[2021]G19(GBP-04A-06-2)地塊國有建設用地使用權競買,以4513萬元的價格競得該地塊使用權,並 與紹興市自然資源和規劃局簽訂了《國有建設用地使用權出讓網上拍賣成交確認書》和《國有建設用地使用權出讓合同》,上述文件已經中華人民共和國浙江省紹興市國信公證處公證。
土地座落:地塊坐落於紹興濱海新區皋埠街道,東至銀洲路,南至優特格爾地塊,西至現狀河道,北至香積路;土地用途:工業用地;土地面積:66,852平方米;出讓年限:50年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.